When monitoring a client treated with fludrocortisone for Addison disease, which assessment should be prioritized alongside urinary output?

When monitoring a client treated with fludrocortisone for Addison disease, prioritizing blood pressure alongside urinary output is essential. Fludrocortisone is a synthetic mineralocorticoid that helps manage the condition by promoting sodium retention and potassium excretion, which helps regulate blood volume and pressure. Since Addison's disease can lead to adrenal insufficiency and related disturbances in fluid and electrolyte balance, blood pressure is a critical indicator of cardiovascular stability.

Monitoring blood pressure allows healthcare providers to assess the effectiveness of fludrocortisone in maintaining adequate fluid balance and ensuring that the patient's circulatory system is supported. Fludrocortisone treatment aims to prevent hypotension, a common risk in patients with adrenal insufficiency. Therefore, tracking blood pressure is crucial to ensure that the medication is working effectively and to adjust dosages if required.

While the other assessments listed—level of consciousness, measures of coagulation, and hydration status—are important in a comprehensive evaluation of the patient, blood pressure provides immediate insight into the patient's hemodynamic status, making it a top priority in monitoring and managing treatment with fludrocortisone.